Analystreport

Stoke Therapeutics, Inc. (NASDAQ: STOK) had its price target lowered by analysts at Credit Suisse Group AG from $50.00 to $38.00.

Stoke Therapeutics, Inc.  (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report